Version 2 2025-03-07, 09:46Version 2 2025-03-07, 09:46
Version 1 2025-02-28, 12:18Version 1 2025-02-28, 12:18
dataset
posted on 2025-03-07, 09:46authored byPsy ShareD
<p dir="ltr"><i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i></p><p dir="ltr"><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with Schizophrenia</b></p><p dir="ltr"><b>Contributors and PI’s:</b> C. J. Aine, H. J. Bockholt, J. R. Bustillo, J. M. Cañive, A. Caprihan, C. Gasparovic, F. M. Hanlon, J. M. Houck, R. E. Jung, J. Lauriello, J. Liu, A. R. Mayer, N. I. Perrone-Bizzozero, S. Posse, J. M. Stephen, J. A. Turner, V. P. Clark, V. D. Calhoun</p><p dir="ltr">Department of Psychology, Georgia State University, Atlanta, GA, USA</p><p dir="ltr"><b><u>Key Details & Variables</u></b></p><pre><table><tr><td></td></tr></table></pre><table><tr><td><p dir="ltr"><b>Age Range</b></p></td><td><p>18-65</p></td></tr><tr><td><p dir="ltr"><b>Number of Participants</b></p></td><td><p>200</p></td></tr><tr><td><p dir="ltr"><b>Diagnostic Criteria</b></p></td><td><p dir="ltr">SCZ</p></td></tr><tr><td><p dir="ltr"><b>Number of Clinical Subjects</b></p></td><td><p>100</p></td></tr><tr><td><p dir="ltr"><b>Number of Clinical Subjects (follow-up)</b></p></td><td><p dir="ltr">No</p></td></tr><tr><td><p dir="ltr"><b>Number of Control Subjects</b></p></td><td><p>100</p></td></tr><tr><td><p dir="ltr"><b>Number of Control Subjects (follow-up)</b></p></td><td><p dir="ltr">No</p></td></tr><tr><td><p dir="ltr"><b>Demographic Information</b></p></td><td><p dir="ltr">Age, Sex, Antipsychotic use, Age of onset, Duration of illness, Handedness, SES, IQ, race</p></td></tr><tr><td><p dir="ltr"><b>Clinical Measures</b></p></td><td><p dir="ltr">PANSS</p></td></tr><tr><td><p dir="ltr"><b>Cognitive Measures</b></p></td><td><p dir="ltr">MATRICS domain scales (Working Memory – spatial & LNS; Speed of Processing – trails, category fluency, symbol coding; Verbal Learning – list learning; Reasoning & problem solving – mazes; visual learning – figure learning; Attention/Vigilance – cont. performance; Social Cognition – manage emotions)</p></td></tr><tr><td><p dir="ltr"><b>Clinical Functioning Measures</b></p></td><td><p dir="ltr">QOL, UPSA</p></td></tr><tr><td><p dir="ltr"><b>Antipsychotic Medication Information Recorded</b></p></td><td><p dir="ltr">Yes</p></td></tr><tr><td><p dir="ltr"><b>Antipsychotic Medication Name/ Antipsychotic Type</b></p></td><td><p dir="ltr">N/A</p></td></tr><tr><td><p dir="ltr"><b>Antipsychotic Dose Recorded</b></p></td><td><p dir="ltr">N/A</p></td></tr><tr><td><p dir="ltr"><b>CPZ Equivalents Recorded</b></p></td><td><p dir="ltr">CPZ (medication dose)</p></td></tr><tr><td><p dir="ltr"><b>Other Medication Variables Recorded</b></p></td><td><p dir="ltr">No</p></td></tr><tr><td><p dir="ltr"><b>Recreational Drug/ Alcohol Use</b></p></td><td><p dir="ltr">No</p></td></tr></table><p><br></p>
Funding
NIH COBRE Phase I grant (1P20RR021938, Lauriello, PI and 2P20GM103472, Calhoun, PI) awarded to the Mind Research Network.
Scanner:
Siemens 3T TIM Trio
Acquisition Details:
5-echo multi-echo MPRAGE sequence
TR = 2.53 s
TE = 1.64, 3.5, 5.36, 7.22, 9.08 ms
Flip Angle = 7°
Field of View = 256 mm